The usefulness of assessing the serum levels of homocysteine in diagnosis of atherosclerosis;Przydatność oznaczeń homocysteiny w diagnostyce miażdżycy naczyń

Acta Angiologica

Volumn 11, Issue 2, 2005, Pages 114-120

  Kokocińska, Danuta ^a,b   Cierpka, Lech ^a   Chmiel, Bogdan ^a   Duraj, Marian ^a   Partyka, Robert ^a   Cierpka, Szymon ^a   Kocot, Jacek ^a   Wieczorek, Piotr ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Samodzielna Pracownia Immunodiagnostyki Klinicznej   (Poland)

Author keywords

Abdominal; Aortic aneurysm; Atherosclerosis; Brain infarction; Coronary artery bypass; Homocysteine; Intermittent claudication; Myocardial infarction; Renal artery obstruction

Indexed keywords

HOMOCYSTEINE;

ABDOMINAL AORTA ANEURYSM; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC VALUE; ENDOTHELIUM INJURY; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; LEG BLOOD FLOW; MAJOR CLINICAL STUDY; POLAND; RISK FACTOR; STROKE;

EID: 21444432713     PISSN: 1234950X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Palasik W, Fiszer U (2001) Homocysteina - kolejny niezałeżny czynnik ryzyka wystȩpowania miażdżycy i niedokrwiennego udaru mózgu. Służba Zdrowia 8-12 listopada 2001: 20-21.
2. Palasik W (2001) Homocysteina - czynnik ryzyka wystȩpowania niedokrwiennego udaru mózgu. Postȩpy Nauk Medycznych, 14: 18-20.
3. Jacobsen DW (1998) Homocysteine and vitamins in cardiovascular disease. Clin Chem, 44: 1833-1843.
4. Mayer EL, Jacobsen DW, Robinson K (1996) Homocysteine and coronary atherosclerosis. J Am Coll Cardiol, 27: 517-527.
5. Liao JK, Shin WS, Lee WY, Clark SL (1995) Oxidised low-density lipoproteins decreases the expression of endothelial nitric oxide synthase. J Biol Chem, 270: 319-324.
6. Sanders PW, Chen PY, Gaston RS (1995) L-arginine and nitric oxide in the regulation of blood pressure. In Hypertension: pathophysiology, diagnosis and man agement. Laragh JH, Brenner BM, Raven Press, New York 1097-1108.
7. DeFalco M, Pollio F, Scaramellino M (2000) Homocysteinemia during pregnancy and placental disease. Clin Exp Obstet Gynecol, 27: 188-90.
8. Dimitrova KR, DeGroot K, Myers AK, Kim YD (2002) Estrogen and homocysteine. Cardiovasc-Res, 53: 577-588.
9. Ubbink JB, Becker PJ, Vennaak WJ, Delport R (1995) Results of B-vitamm in supplementation study used in a prediction mode T to define a reference range for plasma homocysteine. Clin Chem, 41: 1033-1037.
10. Bushnell CD, Goldstein LB (2002) Homocysteine testing in patients with acute ischemic stroke. Neurology, 59: 1541-1546.
11. den-Heijer T, Vermeer SE, Clarke R (2003) Homocysteine and brain atrophy on MRI of non-demented elderly, Brain a Journal of Neurology, 126(Pt 1): 170-175.
12. Domagała B, Sanak M, Czachór R, Szczeklik A (1997) Hiperhomocysteinemia i jej zwia̧zek z miażdżyca̧ tȩtnic. Pol Arch Med Wew, 98: 153-162.
13. van-Wersch JW, Janssensf I, Zandvoort J (2002) Folic acid, Vitamin B(12), and homocysteine in smoking and non-smoking pregnant women. Eur J Obstet Gynecol Reprod Biol, 103: 18-21.
14. Waniek A, Wysocki J, Chora̧ż M (1990) Rola wolnych rodników w patologii człowieka. Pol Tyg Lek, 45: 195-199.
15. Wasilewska A, Szydłowska-Łysiak W (1999) Rola homocysteiny jako źródta dysfunkcji śródbłonka naczyń: niezależny czynnik ryzyka miażdżycy. Żywienie człowieka i metabolizm, XXVI, nr 3.
16. Guilland J, Forier A, Potier De Couray G (2003) Alpha Hyperhomocysteinemiae facteur de risque cardiovasculaire on simple margneur? Pathol Biol, 51: 101-110.
17. Cisternas M, Gutierrez MA, Klaassen J (2002) Cardiovascular risk factors in Chilean patients with rheumatoid arthritis. J Rheum, 29: 1619-1622.
18. Suliman ME, Stenvinkel P, Barany P (2003) Hiperhomocysteinemia and its relationship to cardivascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 41 (3 Suppl 2): 89-95.
19. Kim KN, Kim YJ, Chang N (2004) Effects of the interaction between the C677T 5, 10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women. Eur J Clin Nutr, 58: 10-16.
20. Hirsch S, Pia De la Maza M (2002) Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation. Clin Cardiol, 25: 495-501.
21. Ubbink JB, van der Merve A, Delport A et al (1996) The effect of subnormal vitamin B6 status on homocysteine metabolism. J Clin Invest, 98: 177-184.